학술논문

Prophylactic Lymphadenectomy in Patients with Penile Cancer: Is Sooner Better?
Document Type
Article
Source
Uro. Dec2023, Vol. 3 Issue 4, p251-261. 11p.
Subject
*PENILE cancer
*LYMPHADENECTOMY
*CANCER patients
*RANDOMIZED controlled trials
*OVERALL survival
*PROGRESSION-free survival
Language
ISSN
2673-4397
Abstract
Background: Management of penile cancer patients has its grey zones. In particular, no strong evidence or recommendations exist regarding the timing of prophylactic lymphadenectomy. Here, we aim to review the impact that the timing of inguinal and pelvic prophylactic lymph node dissection has on patient outcome. Methods: All relevant databases were searched following the preferred reporting items for systematic reviews and meta-analysis guidelines. A narrative review of indications for lymph node dissection and pathological considerations precede a systematic review of the impact of prophylactic lymph node dissection timing on prognosis. The primary endpoint is disease-free and overall survival in patients undergoing early or late lymph node dissection after penile cancer diagnosis. Results: Four clinical trials, all focusing on the role of inguinal lymph node dissection, are included. Despite the lack of randomized and controlled trials, this review suggests that lymph node dissection should be performed as soon as possible after diagnosis, with 3 months as a realistic cut-off. Conclusions: Survival of penile cancer patients is strictly related to the timing of prophylactic pelvic lymph node dissection. All patients at high risk of nodal metastasis should be offered lymph node dissection within three months of diagnosis, until new predicting tools are validated. [ABSTRACT FROM AUTHOR]